Increasing research has indicated that EZH2 is widely associated with carcinomas, such as hepatocellular carcinoma, colorectal cancer, melanoma and neuroendocrine tumors (Xiao 2019a; Di 2019; Emran 2019; Faviana 2019). Here, EZH2 is linked to hepatocellular carcinoma.